Rob Rodrigues

Partner

Bio

Rob Rodrigues is a seasoned litigator specializing in high-stakes business and intellectual property disputes in Brazil. Renowned for his strategic acumen, Rob delivers unmatched expertise to FORTUNE 500 companies and dynamic startups alike. He expertly navigates complex legal landscapes, ensuring robust patent portfolio management for top-tier life sciences and telecommunications firms. His deep market insight positions him as a first-choice advisor for both acquisition and enforcement actions.

Rob's excellence has been recognized by a number of leading publications. In 2024, Lexology listed him as a Legal Influencer in Dispute Resolution. Chambers describes Rob as a "superb litigator", "a very competent professional", and "outstanding in providing business-oriented advice." Who's Who Legal praises "his top-tier practice advising clients on life sciences-related patent litigation." The Legal 500 reports that clients describe Rob as someone "who stands out for his strong background in both the IP area, both in terms of litigation and in relation to more technical topics." Client testimonials in IAM Strategy 300 laud him for his "deep understanding of IP issues and keen strategic insight, which he leverages to add value and monetise portfolios."

Throughout his career, Rob has spearheaded multiple preliminary injunction proceedings and trials for global companies in Brazil. He also facilitates monumental IP asset transactions, with a keen eye on managing risks.

A Stanford Law School LL.M. alumnus, Rob served as a lead editor of the Stanford Technology Law Review. He has contributed extensively to global technology law journals and currently holds an editorial role at the Kluwer IP Blog.

Education

LL.M. in Law, Science and Technology, from Stanford Law School.

Residential Scholarship at Hoover IP2 Summer Teaching Institute.

J.D. from Universidade Federal do Rio de Janeiro (UFRJ).

Languages

Portuguese, English, Spanish

Publications

Life Sciences & Healthcare Patents
Life Sciences & Healthcare Patents

Brazil: An Unregulated “Pharmaceutical Orange Book”? New patent-intelligence cooperation has a story to tell

Brazil’s Ministry of Health and ABIFINA partnered on a patent-intelligence agreement to improve patent information use in the SUS, establishing a system akin to the US FDA’s Orange Book.
2025
4
min read
Legal & Regulatory Updates
Legal & Regulatory Updates

The Apple-EU Clash: Engineering Regulation Under the DMA

The article dissects the Apple-EU conflict over the Digital Markets Act, examining the regulation's implications for competition, security, and innovation in tech ecosystems.
2025
6
min read
Legal & Regulatory Updates
Legal & Regulatory Updates

Environmental Liability and Transnational Jurisdiction: The Repercussions of Mariana v. BHP for Private International Law

The Mariana v. BHP case in the English High Court sets significant precedents for transnational environmental liability, applying Brazilian law to the Fundão Dam collapse.
2025
8
min read
Global & Comparative IP
Global & Comparative IP

COP30: why industrial property needs to be at the center of the Brazilian agenda

Brazil's COP30 highlights industrial property's central role in fostering green innovation and a sustainable bioeconomy, crucial for climate leadership and equitable development.
2025
15
min read
Legal & Regulatory Updates
Legal & Regulatory Updates

The Responsibility of Digital Platforms in Brazil Post-Supreme Court: The Partial Unconstitutionality of Article 19 of the Brazilian Civil Rights Framework for the Internet

The Brazilian Supreme Court reinterpreted Article 19 of the Civil Rights Framework, introducing a nuanced liability regime for digital platforms to address illegal content dissemination.
2025
8
min read